Wockhardt founded by Dr. Habil Khorakiwala

Launch of PROXYVON - the first combination formulation in pain management

First in India to bring POVIDONE IODINE (BETADINE) to manage sepsis in collaboration with Mundi Pharma of Switzerland

First modern manufacturing plant commissioned at Chikalthana, Aurangabad

First UK MCA and Australia TGA approval received

Incorporated as Wockhardt Ltd. and listed on the stock exchange

First recombinant product BIOVAC-B launched

Acquisition of CP Pharmaceuticals, UK

Launches India's 1st automatic insulin delivery device: WOSULIN PEN + Cartridges

Only pharmaceutical company in India to be recognised as 'Business Superbrand'

Acquisition of Pinewood Healthcare, Ireland

Acquisition of Morton Grove Pharmaceuticals, USA, & Negma, France

Wins Government of India Patent Award

Wins ‘Best Enterprise’ Award from Europe Business Assembly, Oxford, UK

Celebrates 50 Golden Years

Manufacturing and R&D unit in Dubai

1^st Indian Company to Achieve Approval for EMROK & EMROK O

QIDP for WCK 6777

Wockhardt partners with UK government for COVID-19 vaccine fill & finish

Wockhardt & Jemincare partner for novel respiratory antibiotic Nafithromycin

NIH, USA to conduct human Phase 1 trial of Wockhardt’s novel antibiotic WCK 6777

Wockhardt & Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in UK